Cefuroxime and Catheter site haemorrhage - a phase IV clinical study of FDA data


Catheter site haemorrhage is found among people who take Cefuroxime, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Cefuroxime and have Catheter site haemorrhage. It is created by eHealthMe based on reports of 12,467 people who have side effects when taking Cefuroxime from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2022

12,467 people reported to have side effects when taking Cefuroxime.
Among them, 6 people (0.05%) have Catheter site haemorrhage.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,637 Cefuroxime users for its effectiveness, alternative drugs and more.

What is Catheter site haemorrhage?

Catheter site haemorrhage (bleeding at catheter site) is found to be associated with 649 drugs and 335 conditions by eHealthMe.

Number of Cefuroxime and Catheter site haemorrhage reports submitted per year:

Could Cefuroxime cause Catheter site haemorrhage?

Gender of people who have Catheter site haemorrhage when taking Cefuroxime *:

  • female: 83.33 %
  • male: 16.67 %

Age of people who have Catheter site haemorrhage when taking Cefuroxime *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Cefuroxime *:

  1. Simvastatin: 4 people, 66.67%
  2. Kapidex: 3 people, 50.00%
  3. Hydroxyzine: 3 people, 50.00%
  4. Acyclovir: 3 people, 50.00%
  5. Augmentin: 2 people, 33.33%
  6. Ranitidine: 1 person, 16.67%
  7. Prednisone: 1 person, 16.67%
  8. Imbruvica: 1 person, 16.67%
  9. Augmentin '125': 1 person, 16.67%
  10. Aspirin: 1 person, 16.67%

Common side effects people have besides Catheter site haemorrhage *:

  1. Hypotension (abnormally low blood pressure): 5 people, 83.33%
  2. Oral Candidiasis (fungal infection of mouth): 3 people, 50.00%
  3. Thrombocytopenia (decrease of platelets in blood): 3 people, 50.00%
  4. Activated Partial Thromboplastin Time Prolonged: 3 people, 50.00%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 50.00%
  6. Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 50.00%
  7. Septic Shock (shock due to blood infection): 3 people, 50.00%
  8. Blood Fibrinogen Increased: 3 people, 50.00%
  9. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 3 people, 50.00%
  10. Dehydration (dryness resulting from the removal of water): 3 people, 50.00%

Common conditions people have *:

  1. Herpes Zoster: 3 people, 50.00%
  2. High Blood Cholesterol: 2 people, 33.33%
  3. Cough: 2 people, 33.33%
  4. Oropharyngeal Pain: 1 person, 16.67%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 16.67%
  6. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 16.67%
  7. Acute Myocardial Infarction (acute heart attack): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cefuroxime and have Catheter site haemorrhage?

Check whether Catheter site haemorrhage is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Catheter site haemorrhage and when was it recovered:

Expand to all the drugs that have ingredients of cefuroxime sodium:

Alternative drugs to, pros and cons of Cefuroxime:

Common Cefuroxime side effects:

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Catheter site haemorrhage treatments and more:

COVID vaccines that are related to Catheter site haemorrhage:

Common drugs associated with Catheter site haemorrhage:

All the drugs that are associated with Catheter site haemorrhage:

Common conditions associated with Catheter site haemorrhage:

All the conditions that are associated with Catheter site haemorrhage:

How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime sodium (the active ingredients of Cefuroxime) and Cefuroxime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: